Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


13.11.2017

1 Ann Surg Oncol
1 Biochem Biophys Res Commun
1 BMC Cancer
2 Br J Cancer
2 Br J Dermatol
2 Cancer Res
1 Int J Cancer
3 J Am Acad Dermatol
1 J Invest Dermatol
1 Melanoma Res
1 N Engl J Med
1 Oncol Rep
1 Ophthalmology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. MADU MF, van de Wiel B, van Akkooi ACJ
    Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6169.
    PubMed     Text format    


    Biochem Biophys Res Commun

  2. HE B, Yang D, Qin M, Zhang Y, et al
    Increased cellular uptake of peptide-modified PEGylated gold nanoparticles.
    Biochem Biophys Res Commun. 2017;494.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. CHAGANI S, Wang R, Carpenter EL, Lohr CV, et al
    Ablation of epidermal RXRalpha in cooperation with activated CDK4 and oncogenic NRAS generates spontaneous and acute neonatal UVB induced malignant metastatic melanomas.
    BMC Cancer. 2017;17:736.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. ZUGNA D, Senetta R, Osella-Abate S, Fierro MT, et al
    Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available

  5. HUGDAHL E, Kalvenes MB, Mannelqvist M, Ladstein RG, et al
    Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma.
    Br J Cancer. 2017 Nov 9. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Br J Dermatol

  6. DEL PUERTO C, Navarrete-Dechent C, Molgo M, Camargo CA Jr, et al
    Immunohistochemical expression of vitamin D receptor in melanocytic nevi and cutaneous melanoma. A case-control study.
    Br J Dermatol. 2017 Nov 6. doi: 10.1111/bjd.16103.
    PubMed     Text format     Abstract available

  7. MAHER NG, Guitera P
    Imiquimod treatment for lentigo maligna: LIMIT-1 trial.
    Br J Dermatol. 2017;177:324-325.
    PubMed     Text format    


    Cancer Res

  8. SIERRA RA, Trillo-Tinoco J, Mohamed E, Yu L, et al
    Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance.
    Cancer Res. 2017;77:5628-5638.
    PubMed     Text format     Abstract available

  9. BUCSEK MJ, Qiao G, MacDonald CR, Giridharan T, et al
    beta-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy.
    Cancer Res. 2017;77:5639-5651.
    PubMed     Text format     Abstract available


    Int J Cancer

  10. AITKEN JF, Youlden DR, Baade PD, Soyer HP, et al
    Generational shift in melanoma incidence and mortality in Queensland, Australia, 1995-2014.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31141.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  11. HISCOX B, Hardin MR, Orengo IF, Rosen T, et al
    Reply: Do moderately dysplastic nevi with positive histologic margins need to be reexcised?
    J Am Acad Dermatol. 2017;77:e85.
    PubMed     Text format    

  12. KANTOR J
    Recurrence, evolution, and re-excision of moderately dysplastic nevi.
    J Am Acad Dermatol. 2017;77:e145-e146.
    PubMed     Text format    

  13. HISCOX B, Hardin MR, Orengo IF, Rosen T, et al
    Approach to moderately dysplastic nevi with positive histologic margins.
    J Am Acad Dermatol. 2017;77:e147.
    PubMed     Text format    


    J Invest Dermatol

  14. LOHCHAROENKAL W, Das Mahapatra K, Pasquali L, Crudden C, et al
    Genome-wide screen for microRNAs reveals a role for miR-203 in melanoma metastasis.
    J Invest Dermatol. 2017 Nov 2. pii: S0022-202X(17)33137.
    PubMed     Text format     Abstract available


    Melanoma Res

  15. BRZOZOWSKA M, Wierzba W, Sliwczynski A, Swierkowski M, et al
    Analysis of survival of patients treated with vemurafenib, ipilimumab and dabrafenib for advanced skin melanoma in daily clinical practice (Real-World Data): retrospective analysis of patients treated under drug/reimbursement programmes in Poland in 2
    Melanoma Res. 2017 Nov 8. doi: 10.1097/CMR.0000000000000408.
    PubMed     Text format     Abstract available


    N Engl J Med

  16. SCHUCHTER LM
    Adjuvant Melanoma Therapy - Head-Spinning Progress.
    N Engl J Med. 2017;377:1888-1890.
    PubMed     Text format    


    Oncol Rep

  17. KANG K, Zhang J, Zhang X, Chen Z, et al
    MicroRNA-326 inhibits melanoma progression by targeting KRAS and suppressing the AKT and ERK signalling pathways.
    Oncol Rep. 2017 Nov 2. doi: 10.3892/or.2017.6074.
    PubMed     Text format     Abstract available


    Ophthalmology

  18. LIAO A, Mittal P, Lawson DH, Yang JJ, et al
    Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver.
    Ophthalmology. 2017 Nov 6. pii: S0161-6420(17)32368.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: